Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the efficacy, safety and immunogenicity of MSB11022 and Humira® in adult participants with rheumatoid arthritis (RA).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fresenius Kabi SwissBioSim GmbH
NCT04876781 · Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis, and more
NCT00642629 · Active, Moderate to Severe Rheumatoid Arthritis
MHAT "Trimontium", OOD
Plovdiv
MHAT-Plovdiv AD
Plovdiv
UMHAT "Kaspela", EOOD
Plovdiv
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions